No Cover Image

Journal article 62 views 3 downloads

Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study / Khalid Orayj; Ashley Akbari; Arron S. Lacey; Mathew Smith; Owen Pickrell; Emma L. Lane

Saudi Pharmaceutical Journal, Volume: 29, Issue: 2, Pages: 206 - 212

Swansea University Authors: Ashley, Akbari, Arron S., Lacey, Owen, Pickrell

  • 56151.pdf

    PDF | Version of Record

    © 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license

    Download (556.18KB)
Published in: Saudi Pharmaceutical Journal
ISSN: 1319-0164
Published: Elsevier BV 2021
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa56151
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2021-02-12T12:12:24Z
last_indexed 2021-06-11T03:21:19Z
id cronfa56151
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2021-06-10T10:05:25.3245276</datestamp><bib-version>v2</bib-version><id>56151</id><entry>2021-01-31</entry><title>Factors affecting the choice of first-line therapy in Parkinson&#x2019;s disease patients in Wales: A population-based study</title><swanseaauthors><author><sid>aa1b025ec0243f708bb5eb0a93d6fb52</sid><ORCID>0000-0003-0814-0801</ORCID><firstname>Ashley</firstname><surname>Akbari</surname><name>Ashley Akbari</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>7af5c8bdd1197f85720e4f3d65e803eb</sid><ORCID>0000-0001-7983-8073</ORCID><firstname>Arron S.</firstname><surname>Lacey</surname><name>Arron S. Lacey</name><active>true</active><ethesisStudent>true</ethesisStudent></author><author><sid>1c3044b5ff7a6552ff5e8c9e3901c807</sid><ORCID>0000-0003-4396-5657</ORCID><firstname>Owen</firstname><surname>Pickrell</surname><name>Owen Pickrell</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2021-01-31</date><deptcode>PMSC</deptcode><abstract/><type>Journal Article</type><journal>Saudi Pharmaceutical Journal</journal><volume>29</volume><journalNumber>2</journalNumber><paginationStart>206</paginationStart><paginationEnd>212</paginationEnd><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>1319-0164</issnPrint><issnElectronic/><keywords>Parkinson&#x2019;s disease; Prescribing factors; Social deprivation; L-dopa</keywords><publishedDay>1</publishedDay><publishedMonth>2</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-02-01</publishedDate><doi>10.1016/j.jsps.2021.01.004</doi><url/><notes/><college>COLLEGE NANME</college><department>Medicine</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>PMSC</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-06-10T10:05:25.3245276</lastEdited><Created>2021-01-31T12:43:13.6737298</Created><path><level id="1">Swansea University Medical School</level><level id="2">Medicine</level></path><authors><author><firstname>Khalid</firstname><surname>Orayj</surname><order>1</order></author><author><firstname>Ashley</firstname><surname>Akbari</surname><orcid>0000-0003-0814-0801</orcid><order>2</order></author><author><firstname>Arron S.</firstname><surname>Lacey</surname><orcid>0000-0001-7983-8073</orcid><order>3</order></author><author><firstname>Mathew</firstname><surname>Smith</surname><order>4</order></author><author><firstname>Owen</firstname><surname>Pickrell</surname><orcid>0000-0003-4396-5657</orcid><order>5</order></author><author><firstname>Emma L.</firstname><surname>Lane</surname><order>6</order></author></authors><documents><document><filename>56151__19887__69f860230a984fbe88a8c15df451876b.pdf</filename><originalFilename>56151.pdf</originalFilename><uploaded>2021-05-13T17:03:32.1159790</uploaded><type>Output</type><contentLength>569531</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><action/><documentNotes>&#xA9; 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2021-06-10T10:05:25.3245276 v2 56151 2021-01-31 Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study aa1b025ec0243f708bb5eb0a93d6fb52 0000-0003-0814-0801 Ashley Akbari Ashley Akbari true false 7af5c8bdd1197f85720e4f3d65e803eb 0000-0001-7983-8073 Arron S. Lacey Arron S. Lacey true true 1c3044b5ff7a6552ff5e8c9e3901c807 0000-0003-4396-5657 Owen Pickrell Owen Pickrell true false 2021-01-31 PMSC Journal Article Saudi Pharmaceutical Journal 29 2 206 212 Elsevier BV 1319-0164 Parkinson’s disease; Prescribing factors; Social deprivation; L-dopa 1 2 2021 2021-02-01 10.1016/j.jsps.2021.01.004 COLLEGE NANME Medicine COLLEGE CODE PMSC Swansea University 2021-06-10T10:05:25.3245276 2021-01-31T12:43:13.6737298 Swansea University Medical School Medicine Khalid Orayj 1 Ashley Akbari 0000-0003-0814-0801 2 Arron S. Lacey 0000-0001-7983-8073 3 Mathew Smith 4 Owen Pickrell 0000-0003-4396-5657 5 Emma L. Lane 6 56151__19887__69f860230a984fbe88a8c15df451876b.pdf 56151.pdf 2021-05-13T17:03:32.1159790 Output 569531 application/pdf Version of Record true © 2021 The Authors. Published by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license true eng
title Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
spellingShingle Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
Ashley, Akbari
Arron S., Lacey
Owen, Pickrell
title_short Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
title_full Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
title_fullStr Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
title_full_unstemmed Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
title_sort Factors affecting the choice of first-line therapy in Parkinson’s disease patients in Wales: A population-based study
author_id_str_mv aa1b025ec0243f708bb5eb0a93d6fb52
7af5c8bdd1197f85720e4f3d65e803eb
1c3044b5ff7a6552ff5e8c9e3901c807
author_id_fullname_str_mv aa1b025ec0243f708bb5eb0a93d6fb52_***_Ashley, Akbari
7af5c8bdd1197f85720e4f3d65e803eb_***_Arron S., Lacey
1c3044b5ff7a6552ff5e8c9e3901c807_***_Owen, Pickrell
author Ashley, Akbari
Arron S., Lacey
Owen, Pickrell
author2 Khalid Orayj
Ashley Akbari
Arron S. Lacey
Mathew Smith
Owen Pickrell
Emma L. Lane
format Journal article
container_title Saudi Pharmaceutical Journal
container_volume 29
container_issue 2
container_start_page 206
publishDate 2021
institution Swansea University
issn 1319-0164
doi_str_mv 10.1016/j.jsps.2021.01.004
publisher Elsevier BV
college_str Swansea University Medical School
hierarchytype
hierarchy_top_id swanseauniversitymedicalschool
hierarchy_top_title Swansea University Medical School
hierarchy_parent_id swanseauniversitymedicalschool
hierarchy_parent_title Swansea University Medical School
department_str Medicine{{{_:::_}}}Swansea University Medical School{{{_:::_}}}Medicine
document_store_str 1
active_str 0
published_date 2021-02-01T04:21:18Z
_version_ 1703416827374206976
score 10.803087